Airsculpt Technologies, Inc. SEC filings AIRS

Airsculpt Technologies, Inc. has 249 filings in SEC EDGAR's recent list, going back to Jul 6, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (other events). The company's fiscal year ends on December 31.

Airsculpt Technologies, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Aug 12, 2026 Aug 5, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Shareholder vote results
May 14, 2026 May 12, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 8, 2026 May 8, 2026
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 15, 2026 May 12, 2026
8-K/A Amended current report
Results of operations
Apr 6, 2026 Apr 2, 2026
10-K/A Amended annual report Apr 6, 2026 Dec 31, 2025
8-K Current report
Results of operations
Apr 2, 2026 Apr 2, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
NT 10-K Filing Mar 16, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 16, 2026 Mar 16, 2026
8-K Current report
Officer or director change
Nov 18, 2025 Nov 14, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Results of operations, Officer or director change
Nov 7, 2025 Nov 7, 2025
8-K Current report
Officer or director change
Nov 5, 2025 Nov 4, 2025
10-Q Quarterly report Aug 1, 2025 Jun 30, 2025
8-K Current report
Officer or director change
Aug 1, 2025 Aug 1, 2025
8-K Current report
Results of operations, Officer or director change
Aug 1, 2025 Aug 1, 2025
8-K Current report
Material agreement, Other events
Jun 11, 2025 Jun 9, 2025
424B5 Prospectus supplement Jun 11, 2025 —
424B5 Prospectus supplement Jun 9, 2025 —
8-K Current report
Shareholder vote results
May 8, 2025 May 7, 2025
10-Q Quarterly report May 2, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 2, 2025 May 2, 2025
ARS Annual report to shareholders Mar 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 28, 2025 —
DEF 14A Proxy statement Mar 28, 2025 Dec 31, 2024
EFFECT Filing Mar 24, 2025 —
CORRESP Letter to the SEC Mar 20, 2025 —
UPLOAD Letter from the SEC Mar 20, 2025 —
S-3 Shelf registration Mar 14, 2025 —
10-K Annual report Mar 14, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 14, 2025 Mar 14, 2025
8-K Current report
Results of operations
Jan 13, 2025 Jan 13, 2025
8-K Current report
Officer or director change
Dec 26, 2024 Dec 20, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 17, 2024 Dec 16, 2024
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations, Officer or director change
Nov 8, 2024 Nov 8, 2024
8-K Current report
Results of operations
Oct 24, 2024 Oct 24, 2024
8-K Current report
Material agreement
Sep 13, 2024 Sep 13, 2024
S-8 Employee stock plan registration Aug 12, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 9, 2024 Aug 8, 2024
8-K Current report
Results of operations
Aug 9, 2024 Aug 9, 2024
8-K Current report
Material agreement
Aug 2, 2024 Jul 30, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 10, 2024 May 10, 2024
8-K Current report
Shareholder vote results
May 8, 2024 May 7, 2024
ARS Annual report to shareholders Mar 27, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 27, 2024 —
DEF 14A Proxy statement Mar 27, 2024 Dec 31, 2023
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Results of operations
Oct 5, 2023 Oct 5, 2023
8-K Current report
Regulation FD disclosure
Sep 29, 2023 Sep 29, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 11, 2023 Aug 11, 2023
8-K Current report
Results of operations
Jul 11, 2023 Jul 11, 2023
UPLOAD Letter from the SEC Jun 21, 2023 —
CORRESP Letter to the SEC Jun 15, 2023 —
UPLOAD Letter from the SEC May 17, 2023 —
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 12, 2023 May 12, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 11, 2023 May 10, 2023
CORRESP Letter to the SEC May 8, 2023 —
UPLOAD Letter from the SEC Apr 13, 2023 —
DEFA14A Additional proxy material Mar 31, 2023 —
DEF 14A Proxy statement Mar 31, 2023 Dec 31, 2022
PRE 14A Preliminary proxy statement Mar 21, 2023 Dec 31, 2022
424B3 Prospectus Mar 17, 2023 —
EFFECT Filing Mar 13, 2023 —
S-3/A Filing Mar 13, 2023 —
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023
CORRESP Letter to the SEC Mar 10, 2023 —
10-K Annual report Mar 10, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 10, 2023 Mar 10, 2023
UPLOAD Letter from the SEC Mar 3, 2023 —
S-3 Shelf registration Feb 27, 2023 —
8-K Current report
Officer or director change
Jan 6, 2023 Dec 30, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K Current report
Material agreement, Agreement ended, New debt
Nov 9, 2022 Nov 7, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Material agreement, Results of operations, New debt, Other events
Aug 12, 2022 Aug 12, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Shareholder vote results
May 13, 2022 May 11, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
DEFA14A Additional proxy material Apr 1, 2022 —
DEF 14A Proxy statement Apr 1, 2022 May 11, 2022
10-K Annual report Mar 11, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 11, 2022 Mar 11, 2022
8-K Current report
Officer or director change
Mar 3, 2022 Feb 25, 2022
10-Q Quarterly report Dec 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Dec 3, 2021 Dec 3, 2021
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change
Nov 2, 2021 Oct 28, 2021
S-8 Employee stock plan registration Oct 29, 2021 —
424B4 Prospectus Oct 29, 2021 —
EFFECT Filing Oct 28, 2021 —
CERT Filing Oct 28, 2021 —
8-A12B/A Filing Oct 28, 2021 —
S-1/A Amended registration statement Oct 28, 2021 —
CORRESP Letter to the SEC Oct 27, 2021 —
CORRESP Letter to the SEC Oct 27, 2021 —
8-A12B Form 8-a12b Oct 27, 2021 —
S-1/A Amended registration statement Oct 27, 2021 —
CORRESP Letter to the SEC Oct 20, 2021 —
S-1/A Amended registration statement Oct 20, 2021 —
UPLOAD Letter from the SEC Oct 19, 2021 —
CORRESP Letter to the SEC Oct 5, 2021 —
S-1 Registration statement Oct 5, 2021 —
UPLOAD Letter from the SEC Sep 28, 2021 —
DRS/A Filing Sep 13, 2021 —
DRSLTR Filing Sep 10, 2021 —
UPLOAD Letter from the SEC Aug 26, 2021 —
DRSLTR Filing Aug 13, 2021 —
DRS/A Filing Aug 13, 2021 —
UPLOAD Letter from the SEC Aug 2, 2021 —
DRS Filing Jul 6, 2021 —

Showing 123 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as
AIRS (Nasdaq)
Fiscal year ends
December 31
Headquarters
Tampa, FL
SEC filer status
, Emerging growth company
SEC CIK
1870940

Other Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.